PROSTAGLANDIN A1

Modify Date: 2025-08-22 11:15:22

PROSTAGLANDIN A1 Structure
PROSTAGLANDIN A1 structure
Common Name PROSTAGLANDIN A1
CAS Number 14152-28-4 Molecular Weight 336.466
Density 1.1±0.1 g/cm3 Boiling Point 510.7±50.0 °C at 760 mmHg
Molecular Formula C20H32O4 Melting Point 41 - 43ºC
MSDS Chinese USA Flash Point 276.7±26.6 °C

 Names

Name prostaglandin A1
Synonym More Synonyms

 Chemical & Physical Properties

Density 1.1±0.1 g/cm3
Boiling Point 510.7±50.0 °C at 760 mmHg
Melting Point 41 - 43ºC
Molecular Formula C20H32O4
Molecular Weight 336.466
Flash Point 276.7±26.6 °C
Exact Mass 336.230072
PSA 74.60000
LogP 3.61
Vapour Pressure 0.0±3.0 mmHg at 25°C
Index of Refraction 1.541
Storage condition −20°C
Water Solubility acetone: 10 mg/mL, clear

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
GY5977900
CHEMICAL NAME :
3-Cyclopentene-1-heptanoic acid, 2-(3-hydroxy-1-octenyl)-5-oxo-
CAS REGISTRY NUMBER :
14152-28-4
LAST UPDATED :
198910
DATA ITEMS CITED :
6
MOLECULAR FORMULA :
C20-H32-O4
MOLECULAR WEIGHT :
336.52
WISWESSER LINE NOTATION :
T5V BUTJ D2YQ5 E6VQ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
12 mg/kg
SEX/DURATION :
male 10 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Paternal Effects - other effects on male
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravaginal
DOSE :
169 ug/kg
SEX/DURATION :
female 17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravaginal
DOSE :
169 ug/kg
SEX/DURATION :
female 17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue) Reproductive - Specific Developmental Abnormalities - urogenital system Reproductive - Specific Developmental Abnormalities - other developmental abnormalities
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
10 mg/kg
SEX/DURATION :
female 16 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetal death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
40 mg/kg
SEX/DURATION :
female 16 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - abortion

MUTATION DATA

TYPE OF TEST :
Mutation test systems - not otherwise specified
TEST SYSTEM :
Human Cells - not otherwise specified
DOSE/DURATION :
2500 ug/L
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year: 43,513,1983

 Safety Information

Personal Protective Equipment Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
Hazard Codes Xn
Safety Phrases S22-S24/25
RIDADR NONH for all modes of transport
WGK Germany 3
RTECS GY5977900

 Articles38

More Articles
The cyclopentenone prostaglandin 15d-PGJ2 inhibits the NLRP1 and NLRP3 inflammasomes.

J. Immunol. 194(6) , 2776-85, (2015)

Inflammasomes are cytosolic protein complexes that respond to diverse danger signals by activating caspase-1. The sensor components of the inflammasome, often proteins of the nucleotide-binding oligom...

Protective effects of n-6 fatty acids-enriched diet on intestinal ischaemia/reperfusion injury involve lipoxin A4 and its receptor.

Br. J. Pharmacol. 172(3) , 910-23, (2015)

Long-term intake of dietary fatty acids is known to predispose to chronic inflammation, but their effects on acute intestinal ischaemia/reperfusion (I/R) injury is unknown. The aim of this study was t...

Vimentin filament organization and stress sensing depend on its single cysteine residue and zinc binding.

Nat. Commun. 6 , 7287, (2015)

The vimentin filament network plays a key role in cell architecture and signalling, as well as in epithelial-mesenchymal transition. Vimentin C328 is targeted by various oxidative modifications, but i...

 Synonyms

(13E,15S)-15-Hydroxy-9-oxoprosta-10,13-dien-1-oic acid
(13E,15S)-15-Hydroxy-9-oxoprosta-10,13-dien-1-oic acid PGA1
(13E,15S)-15-Hydroxy-9-oxoprosta-10,13-dien-1-oic acid,PGA1
Prosta-10,13-dien-1-oic acid, 15-hydroxy-9-oxo-, (13E,15S)-
Prostaglandin A1
MFCD00077858
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here

Get all suppliers and price by the below link:

PROSTAGLANDIN A1 suppliers

PROSTAGLANDIN A1 price

Related Compounds: More...
Prostaglandin A1
13641-87-7
GSH-prostaglandin A1
61631-70-7
8-iso-Prostaglandin A1
211186-29-7
15-epi Prostaglandin A1
20897-92-1
Prostaglandin A1 ethyl ester
93464-24-5
Prostaglandin A1 methyl ester
26771-94-8
16,16-dimethyl Prostaglandin A1
41692-24-4
prostaglandin I3
68794-57-0
Prostaglandin B2-d4
211105-23-6
N-(2,5-dimethoxyphenyl)-2-({6-oxo-5-propyl-8-oxa-3,5-diazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),3,10,12-pentaen-4-yl}sulfanyl)acetamide
899961-49-0
N-(2-ethoxyphenyl)-2-((4-oxo-3-propyl-3,4-dihydrobenzofuro[3,2-d]pyrimidin-2-yl)thio)acetamide
900003-94-3
N-(4-methoxyphenyl)-2-({4-oxo-3-[3-(propan-2-yloxy)propyl]-3,4-dihydro[1]benzofuro[3,2-d]pyrimidin-2-yl}sulfanyl)acetamide
900004-14-0
N-(3,4-dimethylphenyl)-2-({4-oxo-3-[3-(propan-2-yloxy)propyl]-3,4-dihydro[1]benzofuro[3,2-d]pyrimidin-2-yl}sulfanyl)acetamide
899741-93-6
N-(2,3-dimethylphenyl)-2-({6-oxo-5-[3-(propan-2-yloxy)propyl]-8-oxa-3,5-diazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),3,10,12-pentaen-4-yl}sulfanyl)acetamide
900004-25-3
N-(2,5-difluorophenyl)-2-((3-(3-isopropoxypropyl)-4-oxo-3,4-dihydrobenzofuro[3,2-d]pyrimidin-2-yl)thio)acetamide
900004-28-6
N-(4-ethylphenyl)-2-({4-oxo-3-[3-(propan-2-yloxy)propyl]-3,4-dihydro[1]benzofuro[3,2-d]pyrimidin-2-yl}sulfanyl)acetamide
900004-31-1
N-(2-ethoxyphenyl)-2-((3-(3-isopropoxypropyl)-4-oxo-3,4-dihydrobenzofuro[3,2-d]pyrimidin-2-yl)thio)acetamide
899962-03-9
2-({4-oxo-3-[3-(propan-2-yloxy)propyl]-3,4-dihydro[1]benzofuro[3,2-d]pyrimidin-2-yl}sulfanyl)-N-(1,3-thiazol-2-yl)acetamide
899742-11-1
N-[(4-methoxyphenyl)methyl]-2-({6-oxo-5-[3-(propan-2-yloxy)propyl]-8-oxa-3,5-diazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),3,10,12-pentaen-4-yl}sulfanyl)acetamide
900004-43-5